Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend

Bulletin Express

06/17

Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.

According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.

No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1130475508"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130475508\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130475508?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130475508","market":"hk","top_or_hot":-1,"title":"Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend","media":"Bulletin Express","content":"<p>Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.</p>\n<p>According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.</p>\n<p>No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-06-17 17:25</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.</p>\n<p>According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.</p>\n<p>No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01466","symbol_name":"佰金生命科學","start_time":0,"source_url":"","article_id":"1130475508","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130475508","pubTimestamp":1781688339,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01466":"佰金生命科学"},"translate_title":"百金生命科学定于6月30日召开董事会批准2026财年业绩并讨论末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01466":1},"content_text":"Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.\nAccording to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.\nNo further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}